Chief Product Officer for Proscia, Nathan Buchbinder, discusses Proscia’s Concentriq and its benefits for CROs and life science organziations.
Applied Clinical Trials
Advertisement
Articles by Applied Clinical Trials
New ASCO study evaluating the cancer care system reveals mixed findings.
Advertisement
Latest Updated Articles
- Report Spotlights Progress, Challenges in Oncology Practice
Published: April 1st 2015 | Updated:
Proscia Launches Commercial Research Edition of Digital Pathology PlatformPublished: April 11th 2019 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Eli Lilly’s Phase II Trial of Eloralintide Shows Up to 20% Weight Reduction in Adults With Obesity
2
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
3
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
4
ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
